Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cantex Pharmaceuticals

Clinical trials sponsored by Cantex Pharmaceuticals, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for glioblastoma? drug combo trial launches Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 1

New hope for glioblastoma? drug combo trial launches

Disease control Ongoing

This phase 2 trial tests the drug azeliragon, taken as a capsule, together with radiation therapy for people with a specific type of glioblastoma (a fast-growing brain cancer). The study includes 30 participants whose tumors lack a certain DNA marker (MGMT unmethylated). The goal…

Phase 2 • Sponsor: Cantex Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC